Unknown

Dataset Information

0

Superior Outcomes With Continuing Tenofovir Versus Switching to Zidovudine in Second-Line Antiretroviral Therapy in Haiti.

ABSTRACT: We compared viral suppression rates between patients who continued tenofovir disoproxil fumarate (TDF)/lamivudine (3TC) vs switched to zidovudine (ZDV)/3TC in combination with a boosted protease inhibitor after failure of first-line efavirenz/TDF/3TC. We found higher rates of viral suppression with continued TDF/3TC compared with switching to ZDV/3TC.

SUBMITTER: Pierre S 

PROVIDER: S-EPMC8661077 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Tenofovir or zidovudine in second-line antiretroviral therapy after stavudine failure in southern Africa.
| S-EPMC4043936 | biostudies-literature
Unknown Superior Effectiveness of Zidovudine Compared With Tenofovir When Combined With Nevirapine-based Antiretroviral Therapy in a Large Nigerian Cohort.
| S-EPMC4725384 | biostudies-literature
Unknown Virologic efficacy of tenofovir, lamivudine and dolutegravir as second-line antiretroviral therapy in adults failing a tenofovir-based first-line regimen.
| S-EPMC7612028 | biostudies-literature
Unknown Cost-effectiveness of tenofovir instead of zidovudine for use in first-line antiretroviral therapy in settings without virological monitoring.
| S-EPMC3414499 | biostudies-literature
Unknown Comparative outcomes of tenofovir-based and zidovudine-based antiretroviral therapy regimens in Lusaka, Zambia.
| S-EPMC3215810 | biostudies-literature
Unknown Week 120 efficacy of tenofovir, lamivudine and lopinavir/r-based second-line antiretroviral therapy in treatment-experienced HIV patients.
| S-EPMC4379083 | biostudies-literature
Unknown Continuing besifovir dipivoxil maleate versus switching from tenofovir disoproxil fumarate for treatment of chronic hepatitis B: Results of 192-week phase 3 trial.
| S-EPMC8046633 | biostudies-literature
Unknown Treatment effect and drug-resistant mutations in Chinese AIDS patients switching to second-line antiretroviral therapy.
| S-EPMC4201507 | biostudies-other
Unknown Early versus standard antiretroviral therapy for HIV-infected adults in Haiti.
| S-EPMC3676927 | biostudies-literature
Unknown Incidence of switching to second-line antiretroviral therapy and associated factors in children with HIV: an international cohort collaboration.
| S-EPMC7093820 | biostudies-literature